May 17, 2020

New parents could soon benefit from personalised videos in UK hospitals

Hospitals
Technology
Hospitals
Technology
Admin
2 min
Parents in UK neonatal units could soon create memorable videos thanks to specialist company vCreate
A new funding initiative is aiming to provide all neonatal care facilities in the UK with the ability to produce personalised videos for parents in the...

A new funding initiative is aiming to provide all neonatal care facilities in the UK with the ability to produce personalised videos for parents in the near future.

Video company vCreate have announced that they’re now looking for corporate sponsors to fund the provision of secure video within the units.

A recent survey by charity Bliss suggested that over 90,000 babies in the country rely on special care and the new funding approach aims to make the technology accessible to the wider neonatal community.

Ben Moore, founder of vCreate, believes that taking a more innovative approach to funding will make all the difference: “It’s clear from our discussions with medics that digital technology such as this has huge potential to transform the way services are delivered across the NHS.

“Delays or lack of central funding can leave the people who deliver the care hamstrung - there’s a proven case for a solution, a need for change, but budget for such initiatives isn’t readily available.”

The Royal Glasgow Hospital for Children has become the first in the UK to trial vCreate’s facilities in their neonatal unit in what's being described as a "successful trial programme".

Ben added: “We’ve already seen how secure video is enhancing patient care at the Royal Hospital for Children in Glasgow, and there’s been widespread media and public interest in the project.”

Neil Patel, Consultant Neonatologist, reckons the video facilities are a useful resource for parents during what can be a difficult time for them. He said: “The idea originally came from a parent of one of our patients.

“He uses personalised video in his work to connect with clients and asked if we could send him video updates of his own baby.

“We then asked more families who all told us there is nothing more reassuring than actually seeing their baby.

“It’s a personalised video platform that makes it quick and simple to create a video which can then be securely accessed by the baby’s parents on any device at any time.”

vCreate believes that the funding proposition delivers for both the public and private sectors. A statement from the company said: “The public sector gains innovative video technology when they need it, and private sector sponsors have the opportunity to support families of premature babies.

“As part of the sponsorship package, corporate sponsors can expect to see their company logo across the vCreate application which would be seen by the parents logging in to watch the videos - plus media coverage across multiple channels, and positive brand and CSR association."

 

Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

AI
NHS
skincancer
Cancer
2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article